
Pancham Bakshi
Examiner (ID: 4910)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1671, 1621 |
| Total Applications | 1480 |
| Issued Applications | 1026 |
| Pending Applications | 167 |
| Abandoned Applications | 342 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18186318
[patent_doc_number] => 11576876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Affinity Medicant Conjugate
[patent_app_type] => utility
[patent_app_number] => 17/347533
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 73
[patent_no_of_words] => 49308
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347533 | Affinity Medicant Conjugate | Jun 13, 2021 | Issued |
Array
(
[id] => 19263493
[patent_doc_number] => 20240207190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/001184
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001184
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001184 | FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY | Jun 7, 2021 | Pending |
Array
(
[id] => 18509993
[patent_doc_number] => 20230226088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 18/009203
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009203
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009203 | THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMS | Jun 6, 2021 | Pending |
Array
(
[id] => 18468785
[patent_doc_number] => 20230203067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => PRODUCTION PROCESS FOR AMINO ALCOHOLATES
[patent_app_type] => utility
[patent_app_number] => 17/998831
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998831 | PRODUCTION PROCESS FOR AMINO ALCOHOLATES | Jun 3, 2021 | Pending |
Array
(
[id] => 18994924
[patent_doc_number] => 11911744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Superabsorbent materials and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/339416
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 6
[patent_no_of_words] => 10229
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339416 | Superabsorbent materials and methods of making the same | Jun 3, 2021 | Issued |
Array
(
[id] => 20129211
[patent_doc_number] => 12371513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Post-crosslinking partial degradation of amide crosslinked hydrogels
[patent_app_type] => utility
[patent_app_number] => 17/334373
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11856
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334373 | Post-crosslinking partial degradation of amide crosslinked hydrogels | May 27, 2021 | Issued |
Array
(
[id] => 18522942
[patent_doc_number] => 20230233592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/999634
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999634 | PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES | May 23, 2021 | Pending |
Array
(
[id] => 17080566
[patent_doc_number] => 20210275572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => METHODS FOR REDUCING CHOLESTEROL WITH SUPERABSORBENT MATERIALS
[patent_app_type] => utility
[patent_app_number] => 17/327037
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327037 | Methods for reducing cholesterol with superabsorbent materials | May 20, 2021 | Issued |
Array
(
[id] => 17080565
[patent_doc_number] => 20210275571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => TREATMENT FOR OBESITY WITH SUPERABSORBENT MATERIALS
[patent_app_type] => utility
[patent_app_number] => 17/327020
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327020 | Treatment for obesity with superabsorbent materials | May 20, 2021 | Issued |
Array
(
[id] => 18348634
[patent_doc_number] => 20230136745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA
[patent_app_type] => utility
[patent_app_number] => 17/918391
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918391 | AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA | May 10, 2021 | Pending |
Array
(
[id] => 18348634
[patent_doc_number] => 20230136745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA
[patent_app_type] => utility
[patent_app_number] => 17/918391
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918391 | AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA | May 10, 2021 | Pending |
Array
(
[id] => 17228589
[patent_doc_number] => 20210355145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/307178
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307178 | PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND | May 3, 2021 | Abandoned |
Array
(
[id] => 17274423
[patent_doc_number] => 20210380621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHOD OF MAKING COBALT COMPOUNDS FOR FEED SUPPLEMENTS
[patent_app_type] => utility
[patent_app_number] => 17/307095
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307095 | Method of making cobalt compounds for feed supplements | May 3, 2021 | Issued |
Array
(
[id] => 18497480
[patent_doc_number] => 20230220121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => USE OF ALKANOLAMINES FOR LIGNIN EXTRACTION IN THE PRETREATMENT OF BIOMASS
[patent_app_type] => utility
[patent_app_number] => 17/925266
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925266 | USE OF ALKANOLAMINES FOR LIGNIN EXTRACTION IN THE PRETREATMENT OF BIOMASS | Apr 28, 2021 | Pending |
Array
(
[id] => 17020883
[patent_doc_number] => 20210244754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
[patent_app_type] => utility
[patent_app_number] => 17/242822
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242822 | Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes | Apr 27, 2021 | Issued |
Array
(
[id] => 17183794
[patent_doc_number] => 20210330679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => PLATINUM-ACRIDINE COMPOUNDS AND METHODS OF TREATING CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/235382
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/235382 | Platinum-acridine compounds and methods of treating cancers | Apr 19, 2021 | Issued |
Array
(
[id] => 18488187
[patent_doc_number] => 20230215535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE
[patent_app_type] => utility
[patent_app_number] => 17/996457
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996457 | METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE | Apr 19, 2021 | Pending |
Array
(
[id] => 18374361
[patent_doc_number] => 20230149440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/918652
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918652 | OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID | Apr 15, 2021 | Pending |
Array
(
[id] => 17005366
[patent_doc_number] => 20210236527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/231367
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231367 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18603372
[patent_doc_number] => 11744812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Methods of treatment
[patent_app_type] => utility
[patent_app_number] => 17/231716
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38979
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231716 | Methods of treatment | Apr 14, 2021 | Issued |